+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 1 Actively Recruiting clinical trials

E

Actively Recruiting

Researchers are evaluating early minimally invasive surgery with thrombolysis eMIST compared to the best medical management in patients with acute spontaneous supratentorial intracerebral hemorrhage ICH of 20 mL or more. This multicenter, randomized, adaptive clinical trial aims to improve functional outcomes after stroke caused by this type of brain hemorrhage. The trial uses a prospective, open-label design with blinded assessment of results and includes adaptive sample size estimation based on interim follow-up data. Participants are randomly assigned to receive either early minimally invasive catheter evacuation followed by up to ten doses of urokinase to dissolve the clot, or the best available standard medical care without surgery. The urokinase doses are administered through a catheter placed directly into the hemorrhage site, aiming for clot resolution. The randomized intervention must start within specific timing windows after stroke onset to be included. During the study, participants undergo assessments including head CT scans, functional evaluations using the utility-weighted modified Rankin Scale at multiple time points up to 180 days, and other measures such as quality of life and daily living activities. Safety and efficacy are monitored throughout the trial, which lasts until study completion in 2028. Researchers focus on functional improvement as the primary outcome, with additional secondary measurements including mortality and clot removal at defined times.

Age: 18Years +All GendersPhase Not Applicable
70 locations